Aleksei Cremo

Aleksei Cremo serves as Vice President of SymBiosis, a venture capital firm focused on investments in biotherapeutics. At SymBiosis, Mr. Cremo helps manage sourcing, due diligence, and execution of investments, and also serves as an advisor to SymBiosis’ portfolio companies. Prior to SymBiosis, Mr. Cremo worked with the Direct and Impact Investment Group of WIT, LLC—an investment management entity affiliated with Walton Enterprises—to support a number of investments in therapeutics companies across a diverse range of geographies, disease areas, and modalities. Mr. Cremo began his career as an Investment Banking Analyst at Perella Weinberg Partners, where he split his time between the firm’s Restructuring and M&A practices, advising both Energy and Pharmaceutical companies. Mr. Cremo holds a BS in Finance from Penn State University.